Advertisement

Psychosocial Aspects of Breast Cancer: Focus on Interventions

  • Kyung Bong KohEmail author
Chapter

Abstract

The psychosocial aspects of breast cancer have received much attention due to the high prevalence and mortality of the disease, as well as the psychological effects of surgery on an organ with high accessory meaning (e.g., body image and self-image, sense of attractiveness, femininity, sexuality, nurturing capacity, and reproduction) [1].

Keywords

Breast Cancer Breast Cancer Patient Major Depressive Disorder Body Image Psychological Intervention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Massie, M. J., & Holland, J. C. (1991). Psychological reactions to breast cancer in the pre- and post-surgical treatment period. Seminars in Surgical Oncology, 7, 320–325.PubMedCrossRefGoogle Scholar
  2. 2.
    Rowland, J. H., & Massie, M. J. (1996). Patient rehabilitation and support. In J. R. Harris, M. E. Lippman, & M. Morrow (Eds.), Disease of the breast. Philadelphia: Lippincott-Raven.Google Scholar
  3. 3.
    Forsén, A. (1991). Psychosocial stress as a risk for breast cancer. Psychotherapy and Psychosomatics, 55, 176–185.PubMedCrossRefGoogle Scholar
  4. 4.
    Kissane, D. W., Bloch, S., & Miach, P. (1997). Cognitive-existential group therapy for patients with primary breast cancer-techniques and themes. Psycho-Oncology, 6, 25–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Kissane, D. W., Clarke, D. M., Ikin, J., et al. (1998). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: A cross-sectional survey. The Medical Journal of Australia, 169, 192–196.PubMedGoogle Scholar
  6. 6.
    Maguire, G. P., Lee, E. G., & Bevington, D. J. (1978). Psychiatric problems in the first year after mastectomy. British Medical Journal, 279, 963–965.CrossRefGoogle Scholar
  7. 7.
    Fallowfield, L. J., Baum, M., & Maguire, G. P. (1986). Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. British Medical Journal, 293, 1331–1334.PubMedCrossRefGoogle Scholar
  8. 8.
    Fallowfield, L. J., Hall, A., Maguire, G. P., et al. (1990). Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. British Medical Journal, 301, 575–580.PubMedCrossRefGoogle Scholar
  9. 9.
    Sprangers, M. A. G., Groenvold, M., & Arraras, J. I. (1996). The European Organization for Research and Treatment of Cancer breast cancer specific quality-of-life questionnaire module. First results from a three country field study. Journal of Clinical Oncology, 14, 2756–2768.PubMedGoogle Scholar
  10. 10.
    Payne, D. K., Sullivan, M. D., & Massie, M. J. (1996). Women’s psychological reactions to breast cancer. Seminars in Oncology, 23(Suppl. 2), 89–97.PubMedGoogle Scholar
  11. 11.
    Vinokur, A. D., Threatt, B. A., Vinokur-Kaplan, D., et al. (1990). The process of recovery from breast cancer for younger and older patients: Changes during the first year. Cancer, 65, 1242–1254.PubMedCrossRefGoogle Scholar
  12. 12.
    Chen, C. C., David, A., Thompson, K., et al. (1996). Coping strategies and psychiatric morbidity in women attending breast assessment clinics. Journal of Psychosomatic Research, 40, 265–270.PubMedCrossRefGoogle Scholar
  13. 13.
    Worden, J. W. (1987). Cognitive therapy with cancer patients. In A. Freeman & V. Greenwood (Eds.), Cognitive therapy: Applications in psychiatric and medical settings. New York: Human Science Press.Google Scholar
  14. 14.
    Fann, J. R., Thomas-rich, A. M., Katon, W. J., et al. (2008). Major depression after breast cancer: A review of epidemiology and treatment. General Hospital Psychiatry, 30, 112–126.PubMedCrossRefGoogle Scholar
  15. 15.
    Massie, M. J., & Holland, J. (1989). Overview of normal reactions and prevalence of psychiatric disorders. In J. C. Holland & J. R. Rowland (Eds.), Handbook of Psycho-oncology. New York: Oxford University Press.Google Scholar
  16. 16.
    Iwamitsu, Y., Shimoda, K., Abe, H., et al. (2005). The relation between negative emotional suppression and emotional distress in breast cancer diagnosis and treatment. Health Communication, 18, 201–215.PubMedCrossRefGoogle Scholar
  17. 17.
    Mamelock, A. E. (1995). Psychiatry and surgery. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive Textbook of Psychiatry. Baltimore: Williams & Wilkins.Google Scholar
  18. 18.
    Lim, C. C., Devi, M. K., & Ang, E. (2011). Anxiety in women with breast cancer undergoing treatment: A systematic review. International Journal of Evidence-Based Healthcare, 9, 215–235.PubMedGoogle Scholar
  19. 19.
    Courtier, N., Gambling, T., Enright, S., et al. (2012). Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Supportive Care in Cancer. doi: 10.1007/s00520-012-1508-6.PubMedGoogle Scholar
  20. 20.
    McGinty, H. L., Goldenberg, J. L., & Jacobsen, P. B. (2012). Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psycho-Oncology, 21, 203–210.PubMedCrossRefGoogle Scholar
  21. 21.
    Cordova, M. J., Andrykowski, M. A., Kenady, D. E., et al. (1995). Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. Journal of Consulting and Clinical Psychology, 63, 981–986.PubMedCrossRefGoogle Scholar
  22. 22.
    Ha, E. H., Seo, J. E., Jeong, J., et al. (2008). Biopsychosocial predictors of depressive disorder in breast cancer patients. Korean Journal of Clinical Psychology, 27, 961–976.Google Scholar
  23. 23.
    Massie, M. J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs, 32, 57–71.PubMedCrossRefGoogle Scholar
  24. 24.
    McDaniel, J. S., Musselman, D. L., Porter, M. R., et al. (1995). Depression in patients with cancer. Diagnosis, biology, and treatment. Archives of General Psychiatry, 52, 89–99.PubMedCrossRefGoogle Scholar
  25. 25.
    Halbreich, U., Rojansky, N., Palter, S., et al. (1995). Estrogen auguments serotonergic activity in postmenopausal women. Biological Psychiatry, 37, 434–441.PubMedCrossRefGoogle Scholar
  26. 26.
    Melzer, H. (1990). Role of serotonin in depression. Annals of the New York Academy of Sciences, 600, 486–495.CrossRefGoogle Scholar
  27. 27.
    Young, E. A., Midgley, A. R., Carson, N. E., et al. (2000). Alteration in the hypothalamic-pituitary-­ovarian axis in depressed women. Archives of General Psychiatry, 57, 1157–1162.PubMedCrossRefGoogle Scholar
  28. 28.
    Harlow, B. L., Wise, L. A., Otto, M. W., et al. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: The Harvard study of moods and cycles. Archives of General Psychiatry, 60, 29–36.PubMedCrossRefGoogle Scholar
  29. 29.
    Sumner, B. E., Grant, K. E., Rosie, R., et al. (1999). Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine (2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Research. Molecular Brain Research, 73, 119–128.PubMedCrossRefGoogle Scholar
  30. 30.
    Cleeland, C. S., Bennett, G. J., Dantzer, R., et al. (2003). Are the symptoms of cancer and cancer treatment due to shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97, 2919–2925.PubMedCrossRefGoogle Scholar
  31. 31.
    Raison, C. L., & Miller, A. H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry, 54, 283–294.PubMedCrossRefGoogle Scholar
  32. 32.
    Dantzer, R. (2001). Cytokine-induced sickness behavior: Where do we stand? Brain, Behavior, and Immunity, 15, 7–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Kronfol, Z., & Remick, D. G. (2000). Cytokines and the brain: Implications for clinical psychiatry. The American Journal of Psychiatry, 157, 683–694.PubMedCrossRefGoogle Scholar
  34. 34.
    Capuron, L., & Dantzer, R. (2003). Cytokines and depression: The need for a new paradigm. Brain, Behavior, and Immunity, 17(suppl. 1), S119–S124.PubMedCrossRefGoogle Scholar
  35. 35.
    Schiepers, O. J., Wichers, M. C., & Maes, M. (2005). Cytokines and major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 201–217.CrossRefGoogle Scholar
  36. 36.
    Spiegel, D. (1997). Psychosocial aspects of breast cancer treatment. Seminars in Oncology, 24, S1-36–S1-47.Google Scholar
  37. 37.
    Lesko, L. M., Massie, M. J., & Holland, J. C. (1987). Oncology. In A. Stoudemire & B. S. Fogel (Eds.), Principles of medical psychiatry. Orlando, FL: Grune & Stratton.Google Scholar
  38. 38.
    Marmor, J. (1979). Short-term dynamic psychotherapy. The American Journal of Psychiatry, 136, 149–155.PubMedGoogle Scholar
  39. 39.
    Kaufman, E., & Micha, V. G. (1987). A model for psychotherapy with the good-prognosis cancer patient. Psychosomatics, 28, 540–547.PubMedCrossRefGoogle Scholar
  40. 40.
    Fiore, N. (1979). Fighting cancer: One patient’s perspective. The New England Journal of Medicine, 300, 284–289.PubMedCrossRefGoogle Scholar
  41. 41.
    Bloom, J. R., Ross, R. D., & Burnell, G. (1978). The effect of social support on patient adjustment after breast surgery. Patient Counselling and Health Education, 1, 50–59.PubMedCrossRefGoogle Scholar
  42. 42.
    La Barba, R. C. (1970). Experimental and environmental factors in cancer. Psychosomatic Medicine, 32, 259–269.Google Scholar
  43. 43.
    Jerse, M. A., Whitman, H. H., & Gustafson, J. P. (1984). Cancer in adults. In H. B. Roback (Ed.), Helping patients and their families cope with medical problems. San Francisco: Jossey-Bass.Google Scholar
  44. 44.
    Janis, E., & Mann, L. (1997). Decision-making. New York: Free Press.Google Scholar
  45. 45.
    Spivack, G., Platt, J., & Schure, M. (1976). The problem-solving approach to adjustment. San Francisco: Jossey-Bass.Google Scholar
  46. 46.
    Benson, H. (1975). The relaxation response. New York: Morrow.Google Scholar
  47. 47.
    Sobel, H. J., & Worden, J. W. (1979). Helping cancer patients cope: A problem solving intervention program for health care professionals. New York: Guilford Press.Google Scholar
  48. 48.
    Burish, T. G., & Lyles, J. N. (1981). Effectiveness of relaxation training in reducing adverse reactions to cancer chemotherapy. Journal of Behavioral Medicine, 4, 65–78.PubMedCrossRefGoogle Scholar
  49. 49.
    Morrow, G. R., & Morrell, B. S. (1982). Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotheray. The New England Journal of Medicine, 306, 1476–1480.CrossRefGoogle Scholar
  50. 50.
    Redd, W. H., Andresen, G. V., & Minagawa, Y. (1982). Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy. Journal of Consulting and Clinical Psychology, 50, 14–19.PubMedCrossRefGoogle Scholar
  51. 51.
    Williams, J. W., Barrett, J., Oxman, T., et al. (2000). Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. Journal of the American Medical Association, 284, 1519–1526.PubMedCrossRefGoogle Scholar
  52. 52.
    Maguire, P., Hopwood, P., Tarrier, N., et al. (1985). Treatment of depression in cancer patients. Acta Psychiatrica Scandinavica. Supplementum, 320, 81–84.PubMedCrossRefGoogle Scholar
  53. 53.
    Morrow, G. R., Hickok, J. T., Roscoe, J. A., et al. (2003). Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trail from the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Clinical Oncology, 21, 4635–4641.PubMedCrossRefGoogle Scholar
  54. 54.
    Thompson, D. S. (2000). Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology. Psychosomatics, 41, 356–359.PubMedCrossRefGoogle Scholar
  55. 55.
    Loprinzi, C. L., Kugler, J. W., Sloan, J. A., et al. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: A randomized controlled trial. Lancet, 356, 2059–2063.PubMedCrossRefGoogle Scholar
  56. 56.
    Loprinzi, C. L., Sloan, J. A., Perez, E. A., et al. (2002). Phase III evaluation of fluoxetine for treatment of hot flashes. Journal of Clinical Oncology, 20, 1578–1583.PubMedCrossRefGoogle Scholar
  57. 57.
    Stearns, V., Issacs, C., Rowland, J., et al. (2000). A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Annals of Oncology, 11, 17–22.PubMedCrossRefGoogle Scholar
  58. 58.
    Soares, C. N., Poitras, J. R., Prouty, J., et al. (2003). Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. The Journal of Clinical Psychiatry, 64, 473–479.PubMedCrossRefGoogle Scholar
  59. 59.
    Kimmick, G. G., Lovato, J., McQuellon, R., et al. (2006). Randomized, double-blind, placebo-­controlled, crossover study of sertraline (zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. The Breast Journal, 12, 114–122.PubMedCrossRefGoogle Scholar
  60. 60.
    Stearns, V., Beebe, K. L., Iyengar, M., et al. (2003). Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. Journal of the American Medical Association, 289, 2827–2834.PubMedCrossRefGoogle Scholar
  61. 61.
    Gordon, P. R., Kerwin, J. P., Boesen, K. G., et al. (2006). Sertraline to treat hot flashes: A randomized controlled, double-blind, crossover trial in a general population. Menopause, 13, 568–575.PubMedCrossRefGoogle Scholar
  62. 62.
    Grassi, L., Biancosino, B., Marmai, L., et al. (2004). Effect of reboxetine on major depressive disorder in breast cancer patients: An open-label study. The Journal of Clinical Psychiatry, 65, 515–520.PubMedCrossRefGoogle Scholar
  63. 63.
    Mathias, C., Cardeal Mendes, C. M., Ponde de Sena, E., et al. (2006). An open-label, fixed-­dose study of bupropion effect on sexual function scores in women treated for breast cancer. Annals of Oncology, 17, 1792–1796.PubMedCrossRefGoogle Scholar
  64. 64.
    Schneider, L. S., Small, G. W., & Clary, C. M. (2001). Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. The American Journal of Geriatric Psychiatry, 9, 393–399.PubMedGoogle Scholar
  65. 65.
    Schneider, L. S., Small, G. W., Hamilton, S. H., et al. (1997). Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine collaborative study group. The American Journal of Geriatric Psychiatry, 5, 97–106.PubMedGoogle Scholar
  66. 66.
    Holland, J. C. (1982). Psychological issues in the care of the terminally ill. In F. Flach (Ed.), Directions in psychiatry. New York: Hatherleigh.Google Scholar
  67. 67.
    Heim, E., Augustiny, K. F., Schaffner, L., et al. (1993). Coping with breast cancer over time and situation. Journal of Psychosomatic Research, 37, 523–542.PubMedCrossRefGoogle Scholar
  68. 68.
    Walker, L. G., & Eremin, O. (1996). Psychological assessment and intervention: Future prospects for women with breast cancer. Seminars in Surgical Oncology, 12, 76–83.PubMedCrossRefGoogle Scholar
  69. 69.
    Pendlebury, S. C., & Snars, J. (1996). Role of a psychiatry liaison clinic in the management of breast cancer. Australasian Radiology, 40, 283–286.PubMedCrossRefGoogle Scholar
  70. 70.
    Spiegel, D. (1996). Cancer and depression. The British Journal of Psychiatry, 30(Suppl.), 109–116.Google Scholar
  71. 71.
    Greer, S., Morris, T., & Pettingale, K. W. (1979). Psychological response to breast cancer: Effect on outcome. Lancet, 2, 785–787.PubMedCrossRefGoogle Scholar
  72. 72.
    Koh, K. B., & Kim, S. T. (1988). Coping strategy of cancer patients. Journal of Korean Neuropsychiatric Association, 27, 140–150.Google Scholar
  73. 73.
    Billings, A. G., & Moos, R. H. (1981). The role of coping responses in attenuating the stress of life events. Journal of Behavioral Medicine, 4, 139–157.PubMedCrossRefGoogle Scholar
  74. 74.
    Smith, L. W., Patterson, T. L., & Grant, I. (1990). Avoidant coping predicts psychological disturbance in the elderly. The Journal of Nervous and Mental Disease, 178, 525–530.PubMedGoogle Scholar
  75. 75.
    Greer, S., & Morrs, T. (1975). Psychological attributes of women who develop breast cancer: A controlled study. Journal of Psychosomatic Research, 19, 147–153.PubMedCrossRefGoogle Scholar
  76. 76.
    Peck, A. (1972). Emotional reactions to having cancer. The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine, 114, 591–599.PubMedCrossRefGoogle Scholar
  77. 77.
    Daune, F. (1995). Psychological aspects of breast cancer. Revue Médicale de Bruxelles, 16, 245–247.PubMedGoogle Scholar
  78. 78.
    Maunsell, E., Jacques, B., & Deschenes, L. (1993). Social support, a survival among women with breast cancer. Presented at the annual Psycho-oncology meeting, Memorial Sloan-Kettering Cancer Center. New York.Google Scholar
  79. 79.
    Spiegel, D., & Kato, P. M. (1996). Psychosocial influences on cancer incidence and progression. Harvard Review of Psychiatry, 4, 10–26.PubMedCrossRefGoogle Scholar
  80. 80.
    Levy, S. M., Herberman, R. B., Whiteside, T., et al. (1990). Perceived social support and tumor- estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosomatic Medicine, 52, 73–85.PubMedGoogle Scholar
  81. 81.
    Wellisch, D. (1980). Psychosocial problems of cancer. In C. M. Haskell (Ed.), Cancer treatment. Philadelphia: WB Saunders.Google Scholar
  82. 82.
    Pfeffenbaum, G., Pasnau, R., & Jamison, K. (1977). A comprehensive program of psychosocial care for mastectomy patients. International Journal of Psychiatry in Medicine, 8, 65–71.Google Scholar
  83. 83.
    Schain, W. S. (1982). Sexual problems of patients with cancer. In V. T. Devita, S. Hellman, & S. A. Rosenberg (Eds.), Cancer: Principles and practices of oncology. Philadelphia: JB Lippincott.Google Scholar
  84. 84.
    Spiegel, D., Bloom, J. R., & Yalom, I. D. (1981). Group support for patients with metastatic cancer: A randomized prospective outcome study. Archives of General Psychiatry, 38, 527–533.PubMedCrossRefGoogle Scholar
  85. 85.
    McGregor, B. A., & Antoni, M. H. (2009). Psychological intervention and health outcomes among women treated for breast cancer: A review of stress pathways and biological mediators. Brain, Behavior, and Immunity, 23, 159–166.PubMedCrossRefGoogle Scholar
  86. 86.
    Andersen, B. L., Yang, H. C., Farrar, W. B., et al. (2008). Psychologic intervention improves survival for breast cancer patients: A randomized clinical trial. Cancer, 113, 3450–3458.PubMedCrossRefGoogle Scholar
  87. 87.
    Nunes, D. F., Rodriguez, A. L., da Silva, H. F., et al. (2007). Relaxation and guided imagery program in patients with breast cancer undergoing radiotherapy is not associated with neuroimmunomodulatory effects. Journal of Psychosomatic Research, 63, 647–655.PubMedCrossRefGoogle Scholar
  88. 88.
    Antoni, M. H., Lechner, S., Diaz, A., et al. (2009). Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain, Behavior, and Immunity, 23, 580–591.PubMedCrossRefGoogle Scholar
  89. 89.
    Andersen, B. L., Farrar, W. B., Golden-Kreutz, D. M., et al. (2004). Psychological, behavioral, and immune changes after a psychological intervention: A clinical trial. Journal of Clinical Oncology, 22, 3570–3580.PubMedCrossRefGoogle Scholar
  90. 90.
    van der Pompe, G., Duivenvoorden, H. J., Antoni, M. H., et al. (1997). Effectiveness of a short-­term group psychotherapy program on endocrine and immune function in breast cancer patients: An exploratory study. Journal of Psychosomatic Research, 42, 453–466.PubMedCrossRefGoogle Scholar
  91. 91.
    Andersen, B. L., Golden-Kreutz, D., Emery, C. F., et al. (2007). Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain, Behavior, and Immunity, 21, 953–961.PubMedCrossRefGoogle Scholar
  92. 92.
    Blomberg, B. B., Alvarez, J. P., Diaz, A., et al. (2009). Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory study. Journal of Psychosomatic Research, 67, 369–376.PubMedCrossRefGoogle Scholar
  93. 93.
    Spiegel, D., Butler, L. D., Giese-Davis, J., et al. (2007). Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial. Cancer, 110, 1130–1138.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of PsychiatryYonsei University College of MedicineSeodaemun-gu, SeoulKorea

Personalised recommendations